Clinical spectrum of gross haematuria following SARS-CoV-2 vaccination with mRNA vaccines.

Publikation

Clinical spectrum of gross haematuria following SARS-CoV-2 vaccination with mRNA vaccines.

Wissenschaftlicher Artikel/Review - 21.12.2021

Ritter Alexander, Helmchen Birgit, Gaspert Ariana, Bleisch Joerg, Fritschi Barbara C., Buchkremer Florian, Damm Stephanie, Schmid Nicolas, Schachtner Thomas, Seeger Harald

Zitation

Ritter A, Helmchen B, Gaspert A, Bleisch J, Fritschi B, Buchkremer F, Damm S, Schmid N, Schachtner T, Seeger H. Clinical spectrum of gross haematuria following SARS-CoV-2 vaccination with mRNA vaccines. Clin Kidney J 2021; 15:961-973.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Clin Kidney J 2021; 15

Veröffentlichungsdatum

21.12.2021

ISSN (Druck)

2048-8505

Seiten

961-973

Kurzbeschreibung/Zielsetzung

Novel messenger RNA (mRNA)-based vaccines play an important role in current vaccination campaigns against SARS-CoV-2. They are highly efficacious and generally well tolerated. Vaccination in patients with immune-mediated kidney diseases is recommended. A number of cases with or relapsing glomerulonephritis shortly after vaccine application have been reported, some of which presented with gross haematuria.